Individual neurons in amygdala and hippocampus encode visual features that help recognize faces, study finds

A total of 27.2 million people of all ages were uninsured in 2024, marking a nonsignificant increase from 25.0 million in 2023, according to early estimates from the National Health Interview Survey, 2024, released by the National Center for Health Statistics.

New research from the University of Pittsburgh School of Medicine and La Jolla Institute for Immunology, published today in Nature Microbiology, reveals an opportunity for developing a therapy against cytomegalovirus (CMV), the leading infectious cause of birth defects in the United States.

In radiation therapy, precision can save lives. Oncologists must carefully map the size and location of a tumor before delivering high-dose radiation to destroy cancer cells while sparing healthy tissue. But this process, called tumor segmentation, is still done manually, takes time, varies between doctors—and can lead to critical tumor areas being overlooked.

A new study from scientists at the Buck Institute for Research on Aging has revealed a surprising player in the battle against Alzheimer's disease and other forms of dementia: brain sugar metabolism. Published in Nature Metabolism, the research uncovers how breaking down glycogen—a stored form of glucose—in neurons may protect the brain from toxic protein buildup and degeneration.

Studies show that the average attention span is now only eight seconds. That's about as much time as it takes to read a few sentences before being distracted.

A pioneering study has provided unprecedented insights into the immune response following pig-to-human kidney xenotransplantation. The findings, presented today at the ESOT Congress 2025, mark a significant step forward in overcoming the biggest challenge in xenotransplantation: rejection by the human immune system.

In the time before widespread vaccination, death often came early.

For years, researchers have seen a connection between exercise and the progression of cognitive disorders such as Alzheimer's—but ramping up movement isn't possible for many patients. A new study published in Nature Neuroscience looks at how to mimic those benefits without having to hit the gym.

From July, eligible Australians will be screened for lung cancer as part of the nation's first new cancer screening program for almost 20 years.

A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional human islets using a novel bioink. Presented today at the ESOT Congress 2025, the new technology could pave the way for more effective and less invasive treatment options for people living with type 1 diabetes (T1D).

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after receiving an advanced stem cell therapy.

Only one in 10 U.S. adults correctly identified testicular cancer as most commonly affecting men under age 40, according to a survey released June16 by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).

With the school holidays approaching, many families will be traveling, including on planes interstate and overseas. But travel can pose unique challenges for people with serious food allergies.

A record heat wave that spread across the East Coast of the United States during the first week of summer has child advocates warning parents and caretakers about the risks of heatstroke to children left inside hot vehicles.

Michigan has its second measles outbreak of the year, Utah has seven cases and health workers in New Mexico are rushing to contain an outbreak in a county jail.

France will ban smoking on beaches and in parks, public gardens and bus shelters from Sunday, the government said.

France on Sunday banned smoking in parks and on beaches, part of efforts to protect the public from passive smoke and create the country's first non-smoking generation.

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new study from St. Jude Children's Research Hospital. Many people with sickle cell disease experience increased brain ischemia, where oxygen is not delivered properly to brain tissues, potentially leading to strokes. A part of the risk for these events comes from increased blood flow speed in the brain. Findings from three patients in a gene therapy clinical trial showed that gene therapy treatment significantly improved blood flow in the brain. These results demonstrate that people with these risk factors may benefit from gene therapy and should be considered for future clinical trials of gene therapy. The findings were published in the American Journal of Hematology.